FDA Approves Moderna, J&J Booster Vaccines for Those 65 and Up

District II Public Health is waiting for approval from the CDC before offering booster doses of the Moderna and J&J vaccines.

District II spokeswoman Natasha Young tells WLHR News, they expect the approval to come today or early next week.

The U.S. Food and Drug Administration has now approved the Moderna and J&J booster vaccines for certain segments of the population.

The FDA took action Wednesday to allow for the use of a single booster dose of the Moderna COVID-19 vaccine six months after the completion of primary series to those age 65 and older, people age 18-64 at high risk of severe COVID-19, and those 18-64 with frequent exposure to the COVID virus.

As for the Johnson&Johnson booster, the FDA ruled a single booster dose of the Janssen (Johnson and Johnson) COVID-19 Vaccine may be administered at least 2 months after completion of the single-dose primary regimen to individuals 18 years of age and older.

They also said it is OK to mix vaccine booster doses following completion of primary vaccination with a different available COVID-19 vaccine.

A single booster dose of the Pfizer-BioNTech COVID-19 Vaccine is available now and may be administered at least 6 months after completion of the primary series to individuals 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2.